Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening
- PMID: 33859050
- PMCID: PMC8461405
- DOI: 10.1136/thoraxjnl-2020-215107
Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening
Abstract
Background: Limited data are available regarding the management of subsolid nodules detected on lung cancer screening with low-dose CT (LDCT). We aimed to determine the characteristics of screen-detected subsolid nodules, and to evaluate the probability of lung cancer and the clinical course of subsolid nodules detected at baseline and during follow-up screening.
Methods: We evaluated 50 132 asymptomatic adults (22 631 never-smokers and 27 501 ever-smokers) who underwent LDCT screening for lung cancer between May 2003 and June 2019 at a tertiary centre in South Korea. The incidence, characteristics and clinical outcomes of the baseline and new screen-detected subsolid nodules were determined.
Results: A total of 6725 subsolid nodules (5116 pure ground glass opacity nodules and 1609 part-solid nodules) were detected in 4545 participants (1484 new subsolid nodules detected in 937 (1.9%) participants; the overall incidence of subsolid nodules: 10.7% in never-smokers and 7.7% in ever-smokers, p<0.001). Among 4918 subsolid nodules that underwent follow-up with CT scans (the mean number of CT scans, including the baseline LDCT scan: 4.6), 2116 nodules (30.0% of baseline subsolid nodules and 78.9% of new subsolid nodules) resolved spontaneously. Among 293 biopsied subsolid nodules, 227 (77.5%) nodules were diagnosed as lung cancer, of which 226 (99.6%) were adenocarcinomas. No significant difference was observed in pathological invasiveness or the initial stage between the baseline and new cancerous subsolid nodules. Multivariable analyses revealed that new detection at follow-up screening was significantly associated with a lower probability of lung cancer (OR 0.26, 95% CI 0.14 to 0.49) and overall growth (OR 0.39, 95% CI 0.26 to 0.59), but with a higher probability of resolution (OR 6.30, 95% CI 5.09 to 7.81).
Conclusions: LDCT screening led to a considerably high rate of subsolid nodule detection, particularly in never-smokers. Compared with the baseline subsolid nodules, the new subsolid nodules were associated with a lower probability of lung cancer and higher probability of spontaneous resolution, indicating their more inflammatory nature. Less aggressive follow-up may be allowed for new subsolid nodules, particularly in screening programmes for Asian populations.
Keywords: lung cancer.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
Beyond the AJR: Incidental Ground-Glass Nodules Found on Low-Dose Screening CT-To Ignore or Not?AJR Am J Roentgenol. 2022 Jan;218(1):190. doi: 10.2214/AJR.21.26303. Epub 2021 Jun 9. AJR Am J Roentgenol. 2022. PMID: 34106754 No abstract available.
Similar articles
-
New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.J Thorac Oncol. 2018 Sep;13(9):1410-1414. doi: 10.1016/j.jtho.2018.05.006. Epub 2018 Jul 12. J Thorac Oncol. 2018. PMID: 29775805 Clinical Trial.
-
Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers.Eur Respir J. 2020 Nov 12;56(5):2000177. doi: 10.1183/13993003.00177-2020. Print 2020 Nov. Eur Respir J. 2020. PMID: 32482786
-
Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.Lancet Respir Med. 2024 Feb;12(2):141-152. doi: 10.1016/S2213-2600(23)00338-7. Epub 2023 Nov 29. Lancet Respir Med. 2024. PMID: 38042167
-
Overview and strategic management of subsolid pulmonary nodules.J Thorac Imaging. 2012 Jul;27(4):240-8. doi: 10.1097/RTI.0b013e31825d515b. J Thorac Imaging. 2012. PMID: 22847591 Review.
-
Evaluating the Patient With a Pulmonary Nodule: A Review.JAMA. 2022 Jan 18;327(3):264-273. doi: 10.1001/jama.2021.24287. JAMA. 2022. PMID: 35040882 Review.
Cited by
-
Management of screening-detected ground glass nodules: a narrative review.Indian J Thorac Cardiovasc Surg. 2024 Mar;40(2):205-212. doi: 10.1007/s12055-023-01595-4. Epub 2023 Sep 15. Indian J Thorac Cardiovasc Surg. 2024. PMID: 38389756 Review.
-
Diagnostic value of artificial intelligence based on computed tomography (CT) density in benign and malignant pulmonary nodules: a retrospective investigation.PeerJ. 2024 Jan 2;12:e16577. doi: 10.7717/peerj.16577. eCollection 2024. PeerJ. 2024. PMID: 38188164 Free PMC article.
-
Managing Persistent Subsolid Nodules in Lung Cancer: Education, Decision Making, and Impact of Interval Growth Patterns.Diagnostics (Basel). 2023 Aug 14;13(16):2674. doi: 10.3390/diagnostics13162674. Diagnostics (Basel). 2023. PMID: 37627933 Free PMC article. Review.
-
A narrative review of the clinical approach to subsolid pulmonary nodules.Ann Transl Med. 2023 Mar 15;11(5):217. doi: 10.21037/atm-22-5246. Epub 2023 Mar 10. Ann Transl Med. 2023. PMID: 37007560 Free PMC article. Review.
-
Long-term follow-up of persistent pulmonary subsolid nodules: Natural course of pure, heterogeneous, and real part-solid ground-glass nodules.Thorac Cancer. 2023 Apr;14(12):1059-1070. doi: 10.1111/1759-7714.14845. Epub 2023 Mar 15. Thorac Cancer. 2023. PMID: 36922372 Free PMC article.
References
-
- Moyer VA US. Preventive services Task force. screening for lung cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330–8. - PubMed
-
- Luo Y-H, Luo L, Wampfler JA, et al. . 5-Year overall survival in patients with lung cancer eligible or ineligible for screening according to US preventive services Task force criteria: a prospective, observational cohort study. Lancet Oncol 2019;20:1098–108. 10.1016/S1470-2045(19)30329-8 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical